Watchlist Price Alert

Vanda Pharmaceuticals Inc... (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

4.33

0.09 (2.12%)

At close: May 23, 2025, 3:59 PM

4.33

0.02%

After-hours: May 23, 2025, 04:47 PM EDT

Vanda Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	198.77M	192.64M	254.38M	268.68M	248.17M	227.19M	193.12M	165.08M	146.02M
Cost of Revenue	11.31M	14.8M	24.28M	25.63M	23.36M	24.49M	20.51M	17.85M	24.71M
Gross Profit	187.46M	177.84M	230.1M	243.05M	224.8M	202.7M	172.61M	147.24M	121.31M
Operating Income	-40.66M	-13.95M	6.33M	42.16M	27.24M	22.81M	21.74M	-16.9M	-18.57M
Interest Income	n/a	n/a	n/a	199K	4.42M	6.22M	n/a	n/a	n/a
Pretax Income	-22.92M	6.34M	11.3M	42.36M	31.66M	29.03M	25.35M	-15.43M	-17.91M
Net Income	-18.9M	2.51M	6.28M	33.15M	23.34M	115.55M	25.21M	-15.57M	-18.01M
Selling & General & Admin	146.41M	112.88M	136.49M	124.05M	140.51M	129.74M	105.75M	123.84M	99.79M
Research & Development	74.43M	76.82M	85.77M	75.36M	55.58M	48.65M	43.59M	38.55M	29.16M
Other Expenses	7.27M	2.09M	1.52M	1.48M	1.48M	1.5M	3.61M	1.47M	665K
Operating Expenses	228.12M	191.8M	223.77M	200.89M	197.56M	179.89M	150.87M	164.14M	139.88M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	500K	2.6M	6.7M	12.6M	3.2M	900K	1.3M	1.4M
Cost & Expenses	239.43M	206.59M	248.05M	226.52M	220.93M	204.38M	171.38M	181.99M	164.59M
Income Tax Expense	-4.02M	3.83M	5.03M	9.21M	8.32M	-86.53M	138K	136K	104K
Shares Outstanding (Basic)	58.15M	57.38M	56.46M	55.55M	54.43M	53.14M	50.86M	44.48M	43.45M
Shares Outstanding (Diluted)	58.15M	57.56M	56.98M	56.92M	55.19M	54.85M	53.05M	44.74M	43.45M
EPS (Basic)	-0.33	0.04	0.11	0.60	0.43	2.17	0.50	-0.35	-0.41
EPS (Diluted)	-0.33	0.04	0.11	0.58	0.42	2.11	0.48	-0.35	-0.41
EBITDA	-32.53M	-10.94M	9.06M	45.01M	30.1M	25.7M	24.69M	-13.92M	-6.7M
EBIT	-40.66M	-13.95M	6.33M	42.16M	31.66M	22.81M	21.74M	-16.9M	-18.57M
Depreciation & Amortization	8.13M	3.01M	2.73M	2.84M	2.86M	2.89M	2.96M	2.98M	11.87M